Three Non-Profit Organizations Selected for Unique Efforts to Advance New Technologies and Understanding of Science CARLSBAD, Calif.–The Life Technologies Foundation today announced that it has awarded $2 million to three grant recipients working to advance science, including the University of North Texas for DNA-PROKIDS, the New York Academy of Sciences and the Science Museum in […]
Clarus Ventures Leads Financing SEATTLE–NanoString Technologies, a privately held life sciences company advancing best-in-class technologies for expression profiling, announced today that it has closed a $30 million Series C equity financing. This financing, structured in two tranches, will allow NanoString Technologies to accelerate the commercialization of the nCounter™ Analysis System in the research tools and […]
New Service and Sales Facility in Shanghai Expands Company’s Global Presence and Support to Asia-Pacific Region AUSTIN, Texas–Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the establishment of an office in Shanghai, People’s Republic of China. The new facility is Luminex’s center of operations in the Asia-Pacific region and will provide […]
02.06.2009 – PEQLAB acquires the manufacturer of their PCR machine range, Primus and peqSTAR. PEQLAB GmbH, the German based supplier of molecular biology products announced yesterday that it has acquired Clemens GmbH, the life sciences electronics company and manufacturer of the peqSTAR range of thermal cyclers. PEQLAB has been the exclusive distributor for Clemens’ thermal […]
Global alliance in biomolecular imaging Uppsala, Sweden, May 28th, 2009 – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation. Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold […]
Fluidigm Europe has announced that the Cancer Research UK Centre for Genetic Epidemiology, University of Cambridge, based at Strangeways Research Laboratory, has purchased the company’s EP1 System to conduct cancer research and disease association studies. The Fluidigm EP1 system combines the efficiencies of integrated fluidic circuit (IFC)-based high-throughput genotyping in a desktop-sized configuration, with a […]
-Latest in Series of Global Distribution Agreements to Make ZyGEM’s Lower-Cost, Rapid and Easy-to-Use DNA Extraction Kits Available to Researchers Everywhere- -ZyGEM Also Announces Issuance of U.S. Patent for its DNA Extraction Technology- SOLANA BEACH, Calif. and HAMILTON, New Zealand and ANN ARBOR, Mich., May 28 — ZyGEM Corp. Ltd. today announced that it has […]
ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on its Octet® Platform MENLO PARK, Calif. — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules – for high-sensitivity protein quantitation and fragment screening, […]
27th May, 2009 Proteome Sciences plc has entered into a license agreement with Axela Inc. for the development of assays to measure its proprietary brain damage biomarkers on Axela’s multiplex biomarker assay dotLab™ System. Proteome Sciences has established a strong portfolio of patent protected blood biomarkers of brain damage-related disorders working in collaboration with the […]
WOBURN, Mass.–SRU Biosystems, a leader in label-free technologies, today announced that the Company has expanded its sales team with the addition of Senior Sales Executives Jane Clark and Rick Loomis to its North American division. Further, the Company announced the appointment of Steve Shamah, Ph.D., as its new Director of Cell Biology and member of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
